Anca Clabbers
8Patents
4h-index
22Co-inventors
49Inventor score
Filing activity: Mar 5, 2010 → Jun 15, 2016
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8835610B2 | IL-17 binding proteins | Emerging Cross-Sectional Technologies | 28 | Active |
| US9663587B2 | IL-17 binding proteins | Emerging Cross-Sectional Technologies | 14 | Active |
| US8779101B2 | IL-17 binding proteins | Emerging Cross-Sectional Technologies | 11 | Active |
| US9655964B2 | Bispecific antibodies directed against TNF-α and IL-17 | Chemistry; Metallurgy | 5 | Active |
| US9481735B2 | IL-17 binding proteins | Emerging Cross-Sectional Technologies | 3 | Active |
| US9803009B2 | Immunobinders directed against TNF | Chemistry; Metallurgy | 2 | Active |
| US9481736B2 | IL-17 binding proteins | Emerging Cross-Sectional Technologies | 2 | Active |
| US9840554B2 | Antibodies against platelet-derived growth factor (PDGF) | Chemistry; Metallurgy | 1 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.